Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Trojani is active.

Publication


Featured researches published by M. Trojani.


British Journal of Cancer | 1992

Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

I de Mascarel; F. Bonichon; J. M. Coindre; M. Trojani

Special techniques such as serial macroscopic sectioning (SMS) or immunohistochemical staining (IH) improve the detection rate of micrometastases but this detection is of value only if it improves the prediction of recurrence and survival. We first studied the prognosis of 120 patients with a single micrometastasis detected by SMS in a series of 1,680 primary operable breast carcinoma with a median follow-up of 7 years. A significant difference in recurrence (P = 0.005) and in survival (P = 0.0369) was found between node-negative patients and those with one single SMS micrometastasis, but SMS micrometastases were not a predicting factor by multivariate analyses according to the Cox model. We then studied the prognostic significance of patients with a micrometastasis detected by IH in node-negative carcinoma: 37 micrometastases from a series of 89 invasive lobular carcinoma (ILC) and 13 single micrometastases from a series of 129 invasive ductal carcinoma (IDC). In the ILC group, IH micrometastases had no prognostic value (median follow-up: 9.3 years). In the IDC group, IH micrometastases were correlated with recurrences (P = 0.01) and were the most significant predicting factor, but were less correlated with survival (median follow-up: 15.6 years). Three main points emerge from this study: (1) SMS micrometastases have a prognostic significance and macroscopic sectioning is recommended as a routine technique not requiring excessive work. (2) IH micrometastases in infiltrating lobular carcinoma have no prognostic significance. (3) The value of IH is debatable in infiltrating ductal carcinoma, since the technique is of principal use in predicting recurrences. It should therefore be carefully assessed vs other prognostic factors currently under study.


British Journal of Cancer | 1987

Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance

M. Trojani; I de Mascarel; F. Bonichon; J. M. Coindre; G. Delsol

Metastases to axillary lymph nodes is an important factor in predicting prognosis and survival in primary operable carcinoma of the breast. A series of post mastectomy lymph nodes (150 cases) was selected in this retrospective study, in which the initial diagnosis had been no metastases by light microscopy and in which a long follow-up was available (average 10 years). The original H&E sections from these cases were immunostained to detect metastases which might not have been previously appreciated. The study was performed using a cocktail of 5 monoclonal antibodies directed against epithelial antigens. The object was to explore the possibility of detection of occult micrometastases by immunohistochemistry and to evaluate their prognostic significance. Micrometastases with individual cells and cell clusters were readily detected by this technique in 14% of all cases. It also became apparent towards the end of the study that micrometastases could be detected with equal sensitivity by any one of the 5 monoclonal antibodies. Positive staining of malignant cells was found to be more frequent in invasive lobular carcinoma (ILC) than in invasive ductal carcinoma (IDC). However, for the IDC group a striking association was found between micrometastases and both recurrence and survival rate. The ILC sample was considered too small for meaningful interpretation. We recommend the use of immunohistochemical techniques using monoclonal antibodies for the detection of occult metastases in lymph nodes to improve the prediction of recurrence and survival in invasive ductal carcinoma of the breast.


European Journal of Cancer | 1998

Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers

I. de Mascarel; F. Bonichon; M. Durand; Louis Mauriac; G. MacGrogan; Isabelle Soubeyran; V. Picot; A. Avril; J. M. Coindre; M. Trojani

This study was conducted to determine the prognostic influence of obvious peritumoral vascular emboli as prospectively determined by a simple routine slide examination in patients with operable node-negative breast cancer. Obvious peritumoral emboli (OPE) were defined by the presence of neoplastic emboli within unequivocal vascular lumina (including both lymphatic spaces and blood capillaries) in areas adjacent to but outside the margins of the carcinoma. OPE were assessed routinely on 5 microns thick haematoxylin and eosin-stained sections for each of 1320 primary operable node-negative breast cancers from 1975 to 1992 at our institution. OPE and other prognostic variables (tumour size, SBR grade, oestrogen and progesterone receptor status) were correlated to overall survival (OS) and metastasis-free interval (MFI) by means of univariate and multivariate analysis with a median follow-up of 103 months. OPE were found in 19.5% of tumours. In univariate analysis, OPE were related to tumour size (P = 6.3 x 10(-5)) and histologic grade (P = 4.9 x 10(-7)). Statistically significant correlations were found with OS (P = 4.6 x 10(-5)) and MFI (P = 6.4 x 10(-9)). Furthermore, in multivariate analysis, OPE was an independent prognostic variable, the most predictive factor for MFI (P = 7.7 x 10(-7)) before tumour size and grade, and was second after tumour grade for OS (P = 0.002). This study on a large unicentric series and with a long follow-up confirms the prognostic significance of vascular emboli in patients with operable node-negative breast carcinoma. Importantly, vascular emboli were found to be accurately detectable by a simple routine and non-time-consuming method. Therefore, such obvious vascular emboli should be considered as an important cost-effective, prognostic variable in patients with node-negative breast carcinoma.


British Journal of Cancer | 1987

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: Detection by immunohistochemistry and prognostic significance

M. Trojani; I de Mascarel; J. M. Coindre; F. Bonichon

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: Detection by immunohistochemistry and prognostic significance


Human Pathology | 1992

Benign lymphocytic angiitis and granulomatosis: A T-cell lymphoma?

B. Vergler; F. Capron; M. Trojani; Eric Labouyrie; Jacky Ferrer; Houchingue Eghbali; J.Ph. Merlio; A. de Mascarei

Benign lymphocytic angiitis and granulomatosis is a T-cell lymphoproliferative disorder confined to the lung and corresponding to a low-grade angiocentric immunoproliferative lesion. Controversy remains as to whether these lesions are lymphomas. We report such a case in an 8-year-old patient with Burkitts lymphoma in remission who presented with persistent bronchopneumopathy and bilateral pulmonary infiltrates on tomodensitometry. Surgical resection revealed the histologic changes of benign lymphocytic angiitis and granulomatosis. Immunohistochemistry showed no aberrant pan T-cell marker loss. Genetic analysis of frozen tissue by Southern blot DNA hybridization with probes to T-cell receptor beta- and gamma-chain genes and to the immunoglobulin heavy chain joining region gene (JH) identified no clonal rearrangement. Search for Epstein-Barr virus-DNA sequences by in situ hybridization and Southern blot analysis provided negative results. Our data imply that lowgrade angiocentric immunoproliferative lesions are not exclusively lymphomas but might represent a borderline lymphoproliferative disease (seen in the course of many diseases), perhaps corresponding to host immune response.


International Journal of Cancer | 1984

Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

M. Trojani; G. Contesso; J. M. Coindre; J. Rouesse; Nguyen Binh Bui; A. De Mascarel; J. F. Goussot; Marc David; F. Bonichon; C. Lagarde


American Journal of Clinical Pathology | 1996

CD30-Positive Cutaneous Large Cell Lymphomas: A Comparative Study of Clinicopathologic and Molecular Features of 16 Cases

Gaëtan MacGrogan; Béatrice Vergier; Pierre Dubus; M. Beylot-Barry; Geneviève Belleannée; Michèle Delaunay; Houchingue Eghbali; Claire Beylot; Jeanine Rivel; M. Trojani; Claude Vital; Antoine de Mascarel; Bertrand Bloch; Jean Ph Merlio


Revue d'imagerie médicale | 1991

Carcinomes tubuleux du sein : aspects radio-cliniques

M. Boisserie-Lacroix; A. Le Treut; B. Jeantet; M. Trojani; F. Bonichon


Hematological Oncology | 2007

Distinctive clinical features between lymphoblastic and immunoblastic non-Hodgkin's malignant lymphomas (Kiel's classification) in a series of 141 patients

B. Hórni; M. Trojani; Houchingue Eghbali; Michel Durand; Jean-Michel Coindre; P. Richaud; Geneviève Hórni‐Simon; C. Lagarde


Annales De Pathologie | 1984

Choriocarcinome primitif de l'estomac. Etude immunohistochimique d'un cas et revue de la littérature

J. F. Goussot; A. De Mascarel; D. Marée; J. M. Coindre; M. Trojani

Collaboration


Dive into the M. Trojani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Bonichon

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Avril

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

E. Bussieres

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

I. de Mascarel

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar

M. Durand

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Tunon de Lara

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Houchingue Eghbali

Argonne National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge